The Chapel Hill Town Council approved a brownfields agreement limiting how the town’s old police HQ property can be ...

No treatments currently exist for the fatty liver disease, but the market could be worth $40 billion in less than 10 years. While most interest was shown in Novartis’ oncology pipeline at its ...

Gilead said it plans to start phase 3 trials later this year. SAN FRANCISCO — New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice ...

Gilead Sciences has declared a quarterly dividend to stockholders on record at the close of business on March 14, 2025. (Reuters) Gilead Sciences, with a market capitalization of $143.8 billion ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly oral dose, raising the hope of a new treatment option for patients.

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.